Rbf Capital, LLC Magenta Therapeutics, Inc. Transaction History

Rbf Capital, LLC

  • $1.96 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023
SELL
$0.41 - $0.86 $37,146 - $77,916
-90,600 Reduced 26.54%
250,822 $198,000
Q4 2022

Feb 14, 2023
SELL
$0.36 - $1.59 $10,800 - $47,700
-30,000 Reduced 8.08%
341,422 $136,000
Q2 2022

Aug 15, 2022
BUY
$0.97 - $3.08 $360,279 - $1.14 Million
371,422 New
371,422 $446,000

Others Institutions Holding MGTA

# of Institutions
2
Shares Held
442K
Call Options Held
0
Put Options Held
0
View Full List

About Magenta Therapeutics, Inc.

MGTA Quotes by TradingView
  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Rbf Capital, LLC Portfolio

Follow Rbf Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rbf Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rbf Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email